Gregory Bailey
Gründer bei SALVARX GROUP PLC
Vermögen: 67 Mio $ am 31.01.2025
Profil
Dr. Gregory H. Bailey, MD, ist ein Chairman bei AgeX Therapeutics, Inc. ein President, Chief Executive Officer & Director bei Juvenescence Ltd. ein Independent Director bei Biohaven Pharmaceutical Holding Co. Ltd, ein Managing Partner bei Mediqventures Ltd, ein Chairman & Head-Business Development bei Portage Biotech, Inc, ein Chairman bei Portage Pharmaceutical Ltd, ein Chief Executive Officer bei Juvenescence, Inc. und ein Director & Chief Business Officer bei Portage Pharma Ltd. Er ist Mitglied des Board of Directors bei Manx Financial Group Plc, Juvenescence Ltd, Biohaven Pharmaceutical Holding Co. Ltd., Prism Technologies LLC, Secure Axcess LLC, Trojan Technologies USA LLC, Portage Pharma Ltd. und SalvaRx Group Plc. Dr. Bailey war zuvor als nicht-geschäftsführender Direktor bei 3Legs Resources Plc, als unabhängiger nicht-geschäftsführender Direktor bei Plethora Solutions Holdings Plc, als geschäftsführender Partner bei Palantir Group, Inc., als unabhängiger Direktor bei Orion Acquisition Corp. II, ein geschäftsführender Direktor bei MDB Capital Group LLC, ein geschäftsführender Direktor bei Knightsford Bank Corp., ein geschäftsführender Direktor bei Knightsford Bank Corp., ein Mitbegründer bei Ascent Healthcare Solutions, Inc. ein geschäftsführender Direktor bei Gilford Securities, Inc. ein Chief Executive Officer bei V. Fund Investments Ltd. ein Mitbegründer bei VirnetX, Inc. und ein Senior Managing Director bei Viscogliosi Brothers LLC. Außerdem war er im Vorstand von PharmaFrontiers Corp., Opexa Therapeutics, Inc., Dura Medic LLC, iWin, Inc. und Sentien Biotechnologies, Inc. Er erhielt seinen Doktortitel von der University of Western Ontario.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
BIOHAVEN LTD.
1.6% | 24.09.2024 | 1 620 071 ( 1.6% ) | 62 Mio $ | 31.01.2025 |
MANX FINANCIAL GROUP PLC
15.33% | 19.06.2024 | 18 346 827 ( 15.33% ) | 4 Mio $ | 31.01.2025 |
PORTAGE BIOTECH INC
15.17% | 31.03.2024 | 170 110 ( 15.17% ) | 750 185 $ | 31.01.2025 |
0.76% | 17.12.2024 | 67 243 ( 0.76% ) | 316 042 $ | 31.01.2025 |
Aktuelle Nachrichten zu Gregory Bailey
Aktive Positionen von Gregory Bailey
Unternehmen | Position | Beginn |
---|---|---|
PORTAGE BIOTECH INC. | Gründer | 01.01.1973 |
SALVARX GROUP PLC | Gründer | 01.01.2007 |
MANX FINANCIAL GROUP PLC | Direktor/Vorstandsmitglied | 07.02.2018 |
BIOHAVEN LTD. | Direktor/Vorstandsmitglied | 28.09.2022 |
Juvenescence, Inc. | Vorstandsvorsitzender | 01.10.2016 |
Juvenescence Ltd.
![]() Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Gründer | 01.10.2016 |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Vorsitzender | 01.06.2013 |
Chelsea Avondale Ltd.
![]() Chelsea Avondale Ltd. Property/Casualty InsuranceFinance Chelsea Avondale Ltd. has developed Skynet, a precision risk technology for property and casualty insurance. The company is based in Hamilton, Bermuda and has subsidiaries in Barbados. Skynet was created by going back to the scientific principles that cause insurance claims. The first implementation of Skynet was completed in Chelsea Avondale's wholly owned Bermudian insurance company, Max Insurance. Chelsea Avondale believes that scientific underwriting is the future of insurance. The company was founded by Gregory H. Bailey and the CEO is Nilesh Mukundrai G. Vasani. | Gründer | - |
Propel LLC (Iowa)
![]() Propel LLC (Iowa) Packaged SoftwareTechnology Services Propel LLC is a private company based in Des Moines, IA and has subsidiaries in the United States. Propel LLC offers fractional executive services with executive-level marketing. The company's fractional executives are experienced and have worked with top corporate brands and successful start-ups. Propel LLC provides diverse and proven subscription-based fractional executives to take businesses to new heights. The company offers fractional chief operating officer solutions to its leading network of fractional chief marketing officers. Propel LLC's rebrand reflects its tagline and motto: move forward today. The company was founded by Gregory H. Bailey, who has been the CEO since incorporation. | Vorstandsvorsitzender | - |
░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Gregory Bailey
Unternehmen | Position | Ende |
---|---|---|
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Gregory Bailey
University of Western Ontario | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
MANX FINANCIAL GROUP PLC | Finance |
BIOHAVEN LTD. | Health Technology |
Private Unternehmen | 32 |
---|---|
PharmaFrontiers Corp. | Health Technology |
Plethora Solutions Holdings Plc
![]() Plethora Solutions Holdings Plc Pharmaceuticals: MajorHealth Technology Plethora Solutions Holdings Plc operates as a pharmaceutical company. It engages in the development and marketing of products for the treatment and management of urological disorders. The firm operates through the Plethora Development and The Urology Co. segments. The Plethora Development segment develops new pharmaceutical products. The Urology Co. segment sells and markets pharmaceutical and healthcare products. The company was founded by Michael Grant Wyllie and Neil Brent Stafford in December 2003 and is headquartered in Chalgrove, the United Kingdom. | Health Technology |
Medivation LLC (California)
![]() Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Palantir Group, Inc.
![]() Palantir Group, Inc. Regional BanksFinance Palantir Group, Inc. biotechnology merchant bank. The company is headquartered in Monkton, MD. | Finance |
Public Ventures LLC
![]() Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
Opexa Therapeutics, Inc.
![]() Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Knightsford Bank Corp. | |
Mediqventures Ltd.
![]() Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance |
Trojan Technologies USA LLC | |
Secure Axcess LLC | |
PRISM Technologies LLC
![]() PRISM Technologies LLC Miscellaneous Commercial ServicesCommercial Services Part of Sabre Corp., PRISM Technologies LLC is a company that provides intellectual property licensing, and technology research and development services. The company is based in Omaha, NE. The company was founded by Gregory J. Duman. PRISM Technologies was acquired by Prism Technologies Group, Inc. on March 30, 2015 for $75.15 million. | Commercial Services |
Dura Medic LLC
![]() Dura Medic LLC Medical DistributorsDistribution Services Dura Medic LLC provides medical products. It supplies durable medical equipment specializing in cost elimination for hospitals and other healthcare providers. The company was founded by Gregory H. Bailey in 2004 and is headquartered in Austin, TX. | Distribution Services |
iWin, Inc.
![]() iWin, Inc. Media ConglomeratesConsumer Services iWin, Inc. develops, publishes and distributes online games for mass market. It offers free, download, ad-supported and online multiplayer games in various categories, including hidden objects, time management, puzzles, logics, jigsaw, action, arcade, adventure, marble shooting, tycoon, card, board, game shows, steals and deals, online party and kids and cash games. The company was founded by Charles J. Wolf, Jr. and David Fox in August 2001 and is headquartered in San Francisco, CA. | Consumer Services |
3Legs Resources Plc
![]() 3Legs Resources Plc Financial ConglomeratesFinance 3Legs Resources Plc engages in the provision of investing in acquire companies within the technology sector. It includes interest in a proposed investment and acquisition. The company was founded on July 22, 2002 and is headquartered in Ramsey, Isle of Man. | Finance |
Sentien Biotechnologies, Inc.
![]() Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA. | Health Technology |
Portage Pharma Ltd.
![]() Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Health Technology |
SalvaRx Group Plc
![]() SalvaRx Group Plc BiotechnologyHealth Technology SalvaRx Group Plc engages in the development of drug that focuses on cancer immune-oncology. Its products portfolio includes iOx therapeutics, intensity therapeutics, nekonal oncology, and rift biotherapeutics. The company was founded by Ian B. Walters and Robert A. Kramer in 2007 and is headquartered in Ramsey, Isle of Man. | Health Technology |
Portage Pharmaceutical Ltd.
![]() Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
AgeX Therapeutics, Inc.
![]() AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
VirnetX, Inc.
![]() VirnetX, Inc. Financial ConglomeratesFinance Part of VirnetX Holding Corp., VirnetX, Inc. is a development stage company focused on real-time communications software. The company is based in Aptos, CA. The company was founded by Gregory H. Bailey, Steve Fu. VirnetX was acquired by PASW, Inc. on July 06, 2007. | Finance |
V. Fund Investments Ltd. | |
Juvenescence, Inc. | Miscellaneous |
Juvenescence Ltd.
![]() Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Finance |
Gilford Securities, Inc.
![]() Gilford Securities, Inc. Investment Banks/BrokersFinance Founded in 1979 by Ralph Worthington and several other senior officers of Blyth Eastman Dillon, Gilford Securities, Inc. is an investment banking firm and registered broker/dealer located in New York City. The firm provides a variety of services to corporations, individuals and institutions. Their research approach is based on fundamental analysis and seeks to remain attentive to market sentiment. Gilford Securities seeks to provide sound financial advice that translates into superior returns for their clients. The firm's research efforts focus concentrates on small/mid-cap growth ideas, specifically, niche/international leaders that stand to benefit from long-term secular trends. Gilford Securities' research coverage includes spans multiple industries, with primary emphasis on the following sectors: (1) information technology and e-Commerce (2) energy (3) retail, consumer and specialty (4) chemicals and pharmaceuticals (5) clean technology and alternative energy and (6) consumer and business services. | Finance |
Viscogliosi Brothers LLC
![]() Viscogliosi Brothers LLC Investment ManagersFinance Viscogliosi Brothers LLC is a venture capital, private equity and merchant banking firm which was founded in 1999 by Marc Viscogliosi, John Viscogliosi and Anthony Viscogliosi. The firm headquartered in New York. | Finance |
Biohaven Pharmaceutical Holding Co. Ltd.
![]() Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Ascent Healthcare Solutions, Inc.
![]() Ascent Healthcare Solutions, Inc. Medical DistributorsDistribution Services Ascent Healthcare Solutions, Inc. provided environmental solutions for hospitals. Its services include the reprocessing (cleaning, testing/verifying, packaging and sterilizing) and remanufacturing (disassembling, repairing, and manufacturing) delicate and costly devices that are marketed in North America as 'single use' by the original manufacturer and often needlessly thrown away. The company was founded in December 2005 and was headquartered in Phoenix, AZ. | Distribution Services |
Chelsea Avondale Ltd.
![]() Chelsea Avondale Ltd. Property/Casualty InsuranceFinance Chelsea Avondale Ltd. has developed Skynet, a precision risk technology for property and casualty insurance. The company is based in Hamilton, Bermuda and has subsidiaries in Barbados. Skynet was created by going back to the scientific principles that cause insurance claims. The first implementation of Skynet was completed in Chelsea Avondale's wholly owned Bermudian insurance company, Max Insurance. Chelsea Avondale believes that scientific underwriting is the future of insurance. The company was founded by Gregory H. Bailey and the CEO is Nilesh Mukundrai G. Vasani. | Finance |
Propel LLC (Iowa)
![]() Propel LLC (Iowa) Packaged SoftwareTechnology Services Propel LLC is a private company based in Des Moines, IA and has subsidiaries in the United States. Propel LLC offers fractional executive services with executive-level marketing. The company's fractional executives are experienced and have worked with top corporate brands and successful start-ups. Propel LLC provides diverse and proven subscription-based fractional executives to take businesses to new heights. The company offers fractional chief operating officer solutions to its leading network of fractional chief marketing officers. Propel LLC's rebrand reflects its tagline and motto: move forward today. The company was founded by Gregory H. Bailey, who has been the CEO since incorporation. | Technology Services |
Medivation, Inc. /Old/ | Health Technology |
Serina Therapeutics (AL), Inc.
![]() Serina Therapeutics (AL), Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Commercial Services |
Culminant Reinsurance Ltd. |